Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
12.21
+0.04 (0.33%)
Jun 27, 2025, 4:00 PM - Market closed
Avanos Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -384.6 | -392.1 | -61.8 | 50.5 | 6.3 | -29 | Upgrade
|
| Depreciation & Amortization | 43.7 | 45.5 | 43.5 | 41.2 | 38.3 | 42.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.1 | 1.2 | 1.9 | 1.1 | 8 | 23.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | 436.7 | 436.7 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 14 | 13.8 | 15.8 | 15.9 | 13.2 | 12.1 | Upgrade
|
| Other Operating Activities | -38.9 | -39.4 | -22.4 | - | -3 | 13.2 | Upgrade
|
| Change in Accounts Receivable | 10.3 | -6.6 | 39 | -24.7 | -10.8 | 45.8 | Upgrade
|
| Change in Inventory | 44.9 | 39 | 4.7 | -30.9 | 15.7 | -19.4 | Upgrade
|
| Change in Accounts Payable | -9.6 | -0.9 | -14.4 | 35.4 | -11.9 | -18.9 | Upgrade
|
| Change in Other Net Operating Assets | 16.8 | 3.5 | -47.3 | -4.1 | 31.5 | -72.9 | Upgrade
|
| Operating Cash Flow | 134.4 | 100.7 | 32.4 | 90.9 | 87.3 | -2.5 | Upgrade
|
| Operating Cash Flow Growth | 330.77% | 210.80% | -64.36% | 4.12% | - | - | Upgrade
|
| Capital Expenditures | -20.4 | -17.8 | -17.8 | -19.3 | -21 | -20.2 | Upgrade
|
| Cash Acquisitions | - | - | -49.6 | -116.1 | - | -4 | Upgrade
|
| Divestitures | - | 2.1 | 89 | - | - | - | Upgrade
|
| Investment in Securities | -14.2 | -11.8 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -34.6 | -27.5 | 21.6 | -135.4 | -21 | -24.2 | Upgrade
|
| Long-Term Debt Issued | - | 20 | 55 | 400 | 20 | 185 | Upgrade
|
| Total Debt Issued | - | 20 | 55 | 400 | 20 | 185 | Upgrade
|
| Long-Term Debt Repaid | - | -53.6 | -119.7 | -296.6 | -70 | -254.8 | Upgrade
|
| Total Debt Repaid | -69.3 | -53.6 | -119.7 | -296.6 | -70 | -254.8 | Upgrade
|
| Net Debt Issued (Repaid) | -69.3 | -33.6 | -64.7 | 103.4 | -50 | -69.8 | Upgrade
|
| Issuance of Common Stock | 1 | 1.1 | 1.3 | 1.7 | 6.2 | 3.4 | Upgrade
|
| Repurchase of Common Stock | -5.9 | -12.8 | -19.1 | -45.5 | -11.5 | -0.9 | Upgrade
|
| Other Financing Activities | -3.3 | -3.8 | -11.7 | -2.9 | - | -2.7 | Upgrade
|
| Financing Cash Flow | -77.5 | -49.1 | -94.2 | 56.7 | -55.3 | -70 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.1 | -4.1 | 0.2 | -3 | -4 | 2.9 | Upgrade
|
| Net Cash Flow | 21.2 | 20 | -40 | 9.2 | 7 | -93.8 | Upgrade
|
| Free Cash Flow | 114 | 82.9 | 14.6 | 71.6 | 66.3 | -22.7 | Upgrade
|
| Free Cash Flow Growth | 757.14% | 467.81% | -79.61% | 7.99% | - | - | Upgrade
|
| Free Cash Flow Margin | 16.54% | 12.05% | 2.17% | 10.47% | 11.29% | -3.18% | Upgrade
|
| Free Cash Flow Per Share | 2.48 | 1.80 | 0.31 | 1.51 | 1.36 | -0.47 | Upgrade
|
| Cash Interest Paid | 11.5 | 11.5 | 14.7 | 8.1 | 3 | 16.8 | Upgrade
|
| Cash Income Tax Paid | 3.3 | 3.3 | 23.6 | -2.9 | -45 | - | Upgrade
|
| Levered Free Cash Flow | 131.31 | 107.88 | 196.13 | -85.26 | 51.3 | -41.7 | Upgrade
|
| Unlevered Free Cash Flow | 138.31 | 115.5 | 205.5 | -79.01 | 53.36 | -31.95 | Upgrade
|
| Change in Net Working Capital | -69.7 | -46 | -137.5 | 139 | -20.3 | 69.5 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.